NEW YORK (GenomeWeb news) – Labcyte said today that Tekon Biotech will serve as exclusive distributor for its low-volume liquid transfer systems in China, Hong Kong, and Taiwan.
Sunnyvale, Calif.-based Labcyte's Echo liquid handlers, which use sound to move liquid, are marketed to pharmaceutical companies and academic and research institutions for use in genomics, proteomics, particle manufacturing, encapsulation, imaging mass spectrometry, and live-cell transfer.
"As we expand in Asia, Tekon will help us broaden our existing user base in the pharmaceutical industry and the contract research organizations that service them," Labcyte's Senior VP of Sales, Marketing, and Service, Stephen Bates, said in a statement.
"We see a great potential market for low-volume transfer devices in China," Tekon CEO David Hadfield said, citing "growing genomics markets, especially for gene expression, SNP analysis, and RNAi."